Association between cytokine gene polymorphisms and outcomes in renal transplantation: A meta-analysis of individual patient data

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 3017-3023

  Thakkinstian, Ammarin ^a,b,i   Dmitrienko, Svetlana ^c   Gerbase DeLima, Maria ^d   McDaniel, D Olga ^e   Inigo, Pablo ^f   Chow, Kai Ming ^g   McEvoy, Mark ^b   Ingsathit, Atiporn ^a   Trevillian, Paul ^h   Barber, William Henry ^e   Attia, John ^b,h  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f HOSPITAL CLÍNIC   (Spain)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^h JOHN HUNTER HOSPITAL   (Australia)

ⁱ Clinical Pharmacology Unit   (Thailand)

Author keywords

Cytokine polymorphisms; Graft failure; Graft rejection; Individual patient meta analysis; Renal transplantation

Indexed keywords

CYTOKINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HLA MATCHING; HUMAN; KIDNEY TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

DELAYED GRAFT FUNCTION; GENOTYPE; GRAFT REJECTION; HUMANS; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 50549088987     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn185     Document Type: Article

References (36)

1. Dmitrienko S, Hoar DI, Balshaw R et al. Immune response gene polymorphisms in renal transplant recipients. Transplantation 2005; 80: 1773-1782
2. Hutchings A, Guay-Woodford L, Thomas JM et al. Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients. Pediatr Transplant 2002; 6: 69-77
3. Loucaidou M, Stitchbury J, Lee J et al. Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression. Transplant Proc 2005; 37: 1760-1761
4. Marshall SE, McLaren AJ, Haldar NA et al. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 2000; 70: 1485-1491
5. McDaniel DO, Barber WH, Nguyan C et al. Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients. Transpl Immunol 2003; 11: 107-119
6. Melk A, Henne T, Kollmar T et al. Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int 2003; 64: 314-320
7. Morgun A, Shulzhenko N, Rampim GF et al. Interleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcome. Transplant Proc 2003; 35: 1344-1345
8. Tian Y, Ma W, Zhang Y. Influence of cytokine gene polymorphism on renal transplantation. Zhonghua Wai Ke Za Zhi 2002; 40: 256-258
9. Tinckam K, Rush D, Hutchinson I et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation 2005; 79: 836-841
10. Weimer R, Mytilineos J, Feustel A et al. Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation 2003; 75: 2090-2099
11. Inigo P, Lario S, Campistol JM et al. Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients. Nefrologia 2003; 23: 312-320
12. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674-677
13. Hernandez JL, Weir BS. A disequilibrium coefficient approach to Hardy-Weinberg testing. Biometrics 1989; 45: 53-70
14. Chen JJ, Thomson G. The variance for the disequilibrium coefficient in the individual Hardy-Weinberg test. Biometrics 1999; 55: 1269-1272
15. Nam J. Simple test for the Hardy-Weinberg law for HLA data with no observed double blanks. Biometrics 1995; 51: 354-357
16. StataCorp. Stata Statistical Software: Release 9.0. Collage Station, TX: Stata Corporation, 2005
17. McCaskie PA, Carter KW, Palmer LJ. SimHap: a comprehensive modelling framework and a simulation-based approach to haplotypic analysis of population-based data, 2004. Available at http://www.genepi.com.au/projects/ simhap/
18. Chow KM, Szeto CC, Poon P et al. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients. Ren Fail 2005; 27: 671-675
19. Thakkinstian A, D'Este C, Attia J. Haplotype analysis of VDR gene polymorphisms: a meta-analysis. Osteoporos Int 2004; 15: 729-734
20. Tagore A, Gonsalkorale WM, Pravica V et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386-390
21. Turner DM, Williams DM, Sankaran D et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8
22. Warle MC, Farhan A, Metselaar HJ et al. Are cytokine gene polymorphisms related to in vitro cytokine production profiles? Liver Transpl 2003; 9: 170-181
23. Hutchinson IV. The role of transforming growth factor-beta in transplant rejection. Transplant Proc 1999; 31: 9S-13S
24. Cerwenka A, Bevec D, Majdic O et al. TGF-beta 1 is a potent inducer of human effector T cells. J Immunol 1994; 153: 4367-4377
25. Swain SL, Huston G, Tonkonogy S et al. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991; 147: 2991-3000
26. Fox FE, Ford HC, Douglas R et al. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms. Cell Immunol 1993; 150: 45-58
27. Morris DR, Kuepfer CA, Ellingsworth LR et al. Transforming growth factor-beta blocks proliferation but not early mitogenic signaling events in T-lymphocytes. Exp Cell Res 1989; 185: 529-534
28. Suthanthiran M. Human renal allograft rejection: molecular characterization. Nephrol Dial Transplant 1998; 13(Suppl 1): 21-24
29. Cuhaci B, Kumar MS, Bloom RD et al. Transforming growth factor-beta levels in human allograft chronic fibrosis correlate with rate of decline in renal function. Transplantation 1999; 68: 785-790
30. Pankewycz OG, Miao L, Isaacs R et al. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity. Kidney Int 1996; 50: 1634-1640
31. Mytilineos J, Laux G, Opelz G. Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 2004; 4: 1684-1690
32. Oxman AD, Clarke MJ, Stewart LA. From science to practice. Meta-analyses using individual patient data are needed. JAMA 1995; 274: 845-846
33. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993; 341: 418-422
34. Smith CT, Williamson PR, Marson AG. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-toevent outcomes. J Eval Clin Pract 2005; 11: 468-478
35. Simmonds MC, Higgins JP. Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data. Stat Med 2007; 26: 2982-2999
36. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573